What is the ticker symbol for Revelation Biosciences?

Revelation Biosciences trades under the ticker REVBU on NASDAQ.

What sector does Revelation Biosciences operate in?

Revelation Biosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze REVBU in a portfolio?

PortView shows REVBU's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Revelation Biosciences (REVBU) Stock Analysis

NASDAQHealthcareBiotechnology

$0.29+3.46%

1-year price historyRange $0.21 – $10.01

52-week range$0.29

$0.15$22.50

What Revelation Biosciences does

Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering new immune system-focused therapeutics and diagnostics. Their pipeline includes a range of therapeutic candidates. Among these is REVTx-99b, currently undergoing a Phase Ib clinical trial for the prevention or management of chronic nasal congestion and allergic rhinitis. Additionally, REVTx-200 is an early-stage, nonclinical asset designed for intranasal administration. Further broadening their therapeutic endeavors, REVTx-300 is an investigational non-clinical stage compound aimed at treating severe organ conditions, such as chronic kidney disease and non-alcoholic steatohepatitis (NASH). On the diagnostic front, Revelation Biosciences is advancing REVDx-501, a rapid, point-of-care in vitro diagnostic test. This kit is engineered to quickly identify various respiratory viral infections, including SARS-CoV-2, Influenza A and B, parainfluenza, and respiratory syncytial virus. Established in 2020, the company's operations are headquartered in San Diego, California.

Key metrics

Market cap

P/E (TTM)

0.00

EPS (TTM)

$0.00

Beta

0.00

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$0.27

200-day avg

$2.83

52-week high

$22.50

52-week low

$0.15

CEO

James M. Rolke

ETFs linked to REVBU

Broad-market and Healthcare sector ETFs an investor holding Revelation Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how REVBU fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze REVBU in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Revelation Biosciences?: Revelation Biosciences trades under the ticker REVBU on NASDAQ.
Which exchange is REVBU listed on?: REVBU is listed on NASDAQ.
What sector does Revelation Biosciences operate in?: Revelation Biosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze REVBU in a portfolio?: PortView shows REVBU's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.